摘要
目的观察芪丹地黄冲剂治疗绝经后骨质疏松症的临床疗效。方法将88例符合纳入标准的患者分为治疗组和对照组,治疗组应用芪丹地黄冲剂治疗,对照组应用强骨胶囊治疗,比较两组治疗前及治疗后3个月临床疗效、腰椎骨密度、肾阳虚症状积分以及相关骨代谢指标的改善情况。结果芪丹地黄冲剂治疗绝经后骨质疏松症,在临床疗效、骨密度、肾虚症状积分以及相关骨代谢指标的改善方面,与中药强骨胶囊具有类似的功用。结论芪丹地黄冲剂治疗绝经后骨质疏松症疗效确切又安全,值得临床推广使用。
Objective To investigate the clinical efficacy of Qi dan di huang Granule to the Postmenopausal Osteoporosis（PMOP）. Methods 88 cases consistent with the inclusion criteria were divided into treatment and control groups, the treatment group was treated with Qi-dan-di-huang granule, the control group was treated with Qiang gu capsule, compared with the situation in clinical efficacy, lumbar bone density, kidney deficiency symptom scores and relevant bone metabolism between the two groups before treatment and 3 months after treatment. Results The treatment group has a similar function with the control group in clinical efficacy, bone mineral density, kidney deficiency symptom scores, as well as relevant bone metabolism. Conclusion The therapy of the Qi-dan-di-huang granule to the PMOP is effective and safe, worthwhile clinical use.
出处
《中国骨质疏松杂志》
CAS
CSCD
2008年第8期573-575,共3页
Chinese Journal of Osteoporosis
关键词
芪丹地黄冲剂
骨质疏松
临床研究
Qi-dan-di-huang granule
Osteoporosis
Clinical research
